Novel approaches in tissue engineering and wound repair close the gap between tissue injury and the shortage of donor tissues for transplant
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Aebischer, P. et al. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer-encapsulated xenogeneic cell line engineered to secrete hCNTF. Human Gene Therapy 7, 851–860 (1996).
Soon-Shiang, P. et al. Insulin dependence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343, 950–951 (1994).
Langer, R. & Vacanti, J.P., Tissue engineering. Science 260, 920–932 (1993).
Hern, D.L. & Hubbell, J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. of Biomed. Materials Res. 39, 266–276 (1998).
Kuhl, P.R. & Griffith-Cima, L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nature Med. 2, 1022–1027 (1996).
Saltzman, W.M. Growth factor delivery in tissue engineering. MRS Bulletin 21, 62–65 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saltzman, W. New encounters with the Sphinx. Nat Med 4, 272–273 (1998). https://doi.org/10.1038/nm0398-272
Issue Date:
DOI: https://doi.org/10.1038/nm0398-272